NIKA · Nika Pharmaceuticals, Inc · Investor Relations
$0.35
At close · Oct 22
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 10, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors, among others, raise substantial doubt about the Company's ability to continue as a going concern. The accompanying financial statements do not include any adjustments that might result from the outcome of this uncertainty.”View the 10-Q filed Aug 10, 2026
Market Cap
$431.19M
Shares
1.05B
Volume · Oct 22
650
Avg daily vol (7 sessions)
1263
Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
No Investor Relations Content
No press releases or events have been collected for this stock yet.